Abbott Touts Favorable Outcomes In Cardiovascular Device Trials
Abbott reports positive trial results for its Amulet 360 LAA occluder and SonicForce coronary IVL system at a conference.
Share
Why It Matters
Abbott's heart device tests showed good results. When a company's medical products work well in tests, it can mean stronger sales later.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.